|
Q1 FY2027
As of Jun 30, 2026
|
Q4 FY2026
As of Mar 31, 2026
|
Q3 FY2026
As of Dec 31, 2025
|
Q2 FY2026
As of Sep 30, 2025
|
Q1 FY2026
As of Jun 30, 2025
|
Q4 FY2025
As of Mar 31, 2025
|
Q3 FY2025
As of Dec 31, 2024
|
Q2 FY2025
As of Sep 30, 2024
|
Q1 FY2025
As of Jun 30, 2024
|
Q4 FY2024
As of Mar 31, 2024
|
Q3 FY2024
As of Dec 31, 2023
|
Q2 FY2024
As of Sep 30, 2023
|
Q1 FY2024
As of Jun 30, 2023
|
Q4 FY2023
As of Mar 31, 2023
|
Q3 FY2023
As of Dec 31, 2022
|
Q2 FY2023
As of Sep 30, 2022
|
Q1 FY2023
As of Jun 30, 2022
|
Q4 FY2022
As of Mar 31, 2022
|
Q3 FY2022
As of Dec 31, 2021
|
Q2 FY2022
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||||||||
| Current Assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Accounts receivable, net of allowance for credit losses | ||||||||||||||||||||
| Subscriptions and warrant exercise receivable (Note 15) | ||||||||||||||||||||
| Subscriptions receivable | ||||||||||||||||||||
| Inventory | ||||||||||||||||||||
| Investments | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Property and Equipment, net | ||||||||||||||||||||
| Other Assets: | ||||||||||||||||||||
| Deferred offering costs | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Patents and trademarks, net | ||||||||||||||||||||
| Licensing Agreement, net | ||||||||||||||||||||
| Investments | ||||||||||||||||||||
| Security deposit | ||||||||||||||||||||
| Total Other Assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Liabilities and Stockholders’ Equity: | ||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Convertible notes and accrued interest | ||||||||||||||||||||
| Accrued expenses – related parties | ||||||||||||||||||||
| Operating lease liabilities – current portion | ||||||||||||||||||||
| Notes payable and accrued interest – current portion | ||||||||||||||||||||
| Convertible notes payable and accrued interest, net of debt discount of $0 and $149,644 (Note 9) | ||||||||||||||||||||
| Derivative liabilities | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Operating lease liabilities (net of current portion) | ||||||||||||||||||||
| Note payable and accrued interest (net of current portion) | ||||||||||||||||||||
| Notes payable and accrued interest (net of current portion) (Note 10) | ||||||||||||||||||||
| Notes payable and accrued interest (net of current portion) (Note 8) | ||||||||||||||||||||
| Total Other Liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Commitments and Contingencies (Note 11) | ||||||||||||||||||||
| Stockholders’ Equity: | ||||||||||||||||||||
| Preferred stock, value | ||||||||||||||||||||
| Series A Preferred Stock | ||||||||||||||||||||
| Series A Convertible Preferred Stock | ||||||||||||||||||||
| Preferred Class A | ||||||||||||||||||||
| Preferred Class B | ||||||||||||||||||||
| Common Stock, par value $0.001, 250,000,000 shares authorized, 37,594,245 and 35,849,919 issued and outstanding at June 30, 2026 and March 31, 2026, respectively | ||||||||||||||||||||
| Common stock to be issued | ||||||||||||||||||||
| Common Stock Receivable | ||||||||||||||||||||
| Additional Paid-In Capital | ||||||||||||||||||||
| Accumulated Deficit | ||||||||||||||||||||
| Total Stockholders’ Equity | ||||||||||||||||||||
| Total Liabilities and Stockholders’ Equity | ||||||||||||||||||||
Loading...
